Remove Doctors Remove FDA Remove Safety Remove Training
article thumbnail

Is DTC effective?

World of DTC Marketing

The old belief is that patients who are interested in new treatments ask their doctor about them. While pharma product websites stop the train for online health seekers, the vast majority fail to provide the information needed to convince people to ask for an advertised product. That belief is out the window. What are the side effects?

article thumbnail

Curavit’s crystal ball – how will 2023 drive meaningful changes in clinical research

pharmaphorum

Prediction 1: the FDA will become more directive and collaborative on guidelines for DCTs. The risk of not having these discussions is to conduct expensive trials only to discover too late that they were measuring the wrong endpoint, in the wrong way, or with a tool or technology the FDA does not accept.

FDA 86
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Horizon of hope: UPLIZNA data, NMOSD, and ECTRIMS

pharmaphorum

That is perhaps why UPLIZNA is the first and only targeted B-cell depleting monotherapy approved by the EMA and the FDA for this disease in adults who have NMOSD and who have the autoantibodies to Aquaporin-4. Throughout her career, she has been passionate about optimising therapeutic interventions for rare autoimmune disorders.

article thumbnail

FDA backs pharmacist prescribing of Paxlovid for COVID

pharmaphorum

Some patients with COVID-19 will be able to get easier access to Pfizer’s oral antiviral therapy Paxlovid, after the FDA ruled that pharmacists would be able to prescribe the drug. Now, in addition to doctors and providers, the FDA announced pharmacists with your medical information can prescribe Paxlovid to patients.

FDA 105
article thumbnail

DTx for women’s mental health – Woebot and postpartum depression

pharmaphorum

Digital therapeutics company Woebot Health has announced enrolment of the first patient in a pivotal clinical trial to evaluate the safety and efficacy of WB001, an investigational therapeutic for postpartum depression (PPD), granted Breakthrough Device designation by the US Food and Drug Administration (FDA) in 2021. Levy asked.

article thumbnail

How to Work with Patient Advocates, Influencers, and Ambassadors

PM360

Be clear in your governance documents and training to level set expectations. For example, everyone must be steeped in both FDA and FTC guidelines. Typically, we think of patient partnerships in terms of their external impact—for example, to help educate doctors and payers. Different patients have unique needs. Anthony Yanni.

article thumbnail

Embedding the Patient Point of View in Everything You Do

PM360

While I like traditional blinded market research projects or online virtual panels, the participants tend to be the “engaged patients” and may not account for the doctor-dependent patients needed to reach to move the market. In April, the FDA released an updated draft guidance identifying steps to improve diversity in clinical trials.